Novartis, BioE join hands for typhoid, paratyphoid vaccines

Switzerland-based drug major Novartis today said it has entered into a development and licensing agreement with Biological E (BioE) for two vaccines against typhoid and paratyphoid fevers.

Novartis, BioE join hands for typhoid, paratyphoid vaccines

Switzerland-based drug major Novartis Monday said it has entered into a development and licensing agreement with Biological E (BioE) for two vaccines against typhoid and paratyphoid fevers.

GSK, Biological E to form JV for developing polio drug

Completion of the transaction is expected in 2013, subject to several conditions including regulatory approval of the joint venture (JV), the statement added.